全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

血栓闭塞性脉管炎的中西医治疗研究进展
Research Progress in the Treatment of Thromboangiitis Obliterans with Traditional Chinese and Western Medicine

DOI: 10.12677/acm.2024.1482184, PP. 74-78

Keywords: 血栓闭塞性脉管炎,中西医治疗,进展
Thromboangiitis Obliterans
, Traditional Chinese and Western Medicine Treatment, Progress

Full-Text   Cite this paper   Add to My Lib

Abstract:

血栓闭塞性脉管炎(Thromboangiitis Obliterans, TAO)是一种主要累及于四肢末端中、小静脉,阶段分布的慢性复发性血管闭塞疾病。本病多见于青壮年时期,目前尚未明确具体病因机制,但一般认为多与吸烟、寒冷刺激、外伤等因素有关。近年来中西医治疗TAO取得了一定的进展,笔者查阅近五年中西医治疗TAO相关文献,下文综述了中西医治疗TAO的研究进展,旨在为临床TAO的治疗提供参考。
Tromboangiitis obliterans (TAO) is a chronic recurrent vascular occlusive disease that mainly involves the middle and venules of the terminal extremities. The disease tends to occur in young adults, and the specific etiology and mechanism is not clear at present, but it is generally believed that is mostly related to smoking, cold stimulation, trauma and other factors. In recent years, some progress has been made in the treatment of TAO in Chinese and western medicine. The author reviewed the relevant literature of TAO in the past five years, and below reviewed the research progress and development trend of TAO in Chinese and western medicine, aiming to provide reference for the treatment of clinical TAO.

References

[1]  陈立强, 吴二利, 张家墉. 血栓闭塞性脉管炎中医药治疗概况[J]. 现代中西医结合杂志, 2021, 30(7): 788-793.
[2]  马立人, 王晓歌. 血栓闭塞性脉管炎的临床研究进展[J]. 血管与腔内血管外科杂志, 2019, 5(6): 553-557.
[3]  李桓, 魏丹丹, 唐静雯, 等. 国医大师唐祖宣辨“痛”治疗血栓闭塞性脉管炎经验[J]. 时珍国医国药, 2022, 33(7): 1750-1752.
[4]  邓蕴源, 林晓光, 江湧, 等. 陈渭良教授论治血栓闭塞性脉管炎临床经验[J]. 四川中医, 2020, 38(10): 14-16.
[5]  崔海燕, 郭继臻, 李贝, 等. 郑学军分期辨证治疗血栓闭塞性脉管炎经验介绍[J]. 山西中医, 2020, 36(2): 6-8.
[6]  张国奇, 曹烨民. 曹烨民扶阳固本法为主治疗血栓闭塞性脉管炎经验[J]. 上海中医药杂志, 2017, 51(3): 23-25.
[7]  黄倩, 李治. 四妙通脉汤加减治疗血栓闭塞性脉管炎的临床疗效观察[J]. 广州中医药大学学报, 2022, 39(1): 62-66.
[8]  王云超. 论“温阳四法”在血栓闭塞性脉管炎的应用[J]. 中医临床研究, 2017, 9(34): 77-79.
[9]  黄永健, 龙舒妮, 杨韵华, 等. 赖氏通元针法结合温针灸治疗血栓闭塞性脉管炎探析[J]. 云南中医学院学报, 2019, 42(2): 65-69.
[10]  龚新彪. 针刺放血配合中药熏洗治疗血栓闭塞性脉管炎40例[J]. 光明中医, 2022, 37(13): 2399-2402.
[11]  秦亚鹏, 赵玉群. 生肌玉红膏促进血栓闭塞性脉管炎(脱疽)患者伤口愈合的临床疗效[J]. 血管与腔内血管外科杂志, 2019, 5(6): 509-512.
[12]  陈品英, 刘建魁. 中药熏吸治疗坏疽期血栓闭塞性脉管炎临床疗效研究[J]. 河北中医药学报, 2021, 36(6): 34-36+45.
[13]  高瑾, 段俊红, 李军. 穴位埋针对血栓闭塞性脉管炎临床疗效的影响[J]. 河北中医药学报, 2021, 36(2): 30-33+47.
[14]  韩春晓, 王娜. 阿加曲班药理作用和临床应用研究进展[J]. 药物评价研究, 2021, 44(10): 2088-2096.
[15]  柴昊, 刘安康, 李骞, 等. 阿加曲班联合前列地尔治疗下肢血栓闭塞性脉管炎的临床效果[J]. 河南医学研究, 2023, 32(10): 1746-1749.
[16]  Sen, I., Agarwal, S., Tharyan, P. and Forster, R. (2018) Lumbar Sympathectomy versus Prostanoids for Critical Limb Ischaemia Due to Non-Reconstructable Peripheral Arterial Disease. Cochrane Database of Systematic Reviews, 2018, CD009366.
https://doi.org/10.1002/14651858.cd009366.pub2
[17]  Cacione, D.G., Moreno, D.H., Nakano, L.C. and Baptista-Silva, J.C. (2017) Surgical Sympathectomy for Buerger’s Disease. JRSM Open, 8, No. 8.
https://doi.org/10.1177/2054270417717666
[18]  吴晔, 胡智飞, 郭伟, 等. 经靶动脉灌注银杏叶提取物治疗血栓闭塞性脉管炎的效果分析[J]. 血管与腔内血管外科杂志, 2017, 3(6): 1044-1048.
[19]  Chahal, A., Malla, S., Sharma, S., Chumber, S. and Madhusudhan, K.S. (2021) CT-Guided Lumbar Sympathectomy as a Last Option for Chronic Limb-Threatening Ischemia of the Lower Limbs: Evaluation of Technical Factors and Long-Term Outcomes. American Journal of Roentgenology, 216, 1273-1282.
https://doi.org/10.2214/ajr.20.23089
[20]  张阳, 孙思翘, 赵文光, 等. 腰交感神经切除术治疗血栓闭塞性脉管炎的研究进展[J]. 吉林大学学报(医学版), 2011, 37(2): 385-388.
[21]  胡威龙, 张小兵. 内膜剥脱术联合腰交感神经节切除术治疗下肢血栓闭塞性脉管炎的效果[J]. 河南医学研究, 2021, 30(2): 254-256.
[22]  韩鹏, 刘冰. 动脉内膜剥脱联合腰交感神经节切除术治疗下肢血栓闭塞性脉管炎的回顾性分析[J]. 中国血管外科杂志(电子版), 2019, 11(3): 179-182+191.
[23]  Uyanık, S.A., Öğüşlü, U., Aminu, I.S., Yılmaz, B., Çevik, H., Atlı, E., et al. (2021) Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) with Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible. American Journal of Roentgenology, 216, 421-427.
https://doi.org/10.2214/ajr.20.23023
[24]  Serefli, D. and Saydam, O. (2022) Endovascular Treatment of Buerger’s Disease in Patients with Critical Limb Ischaemia. Cardiovascular Journal of Africa, 33, 32-37.
https://doi.org/10.5830/cvja-2022-018
[25]  Soliman, M., Mowafy, K., Elsaadany, N., Soliman, R. and Elmetwally, A. (2020) Thromboangiitis Obliterans: Aggressive Angioplasty Provides a Potential Solution (Randomized Pilot Study). SAGE Open Medicine, 8, 1-9.
https://doi.org/10.1177/2050312120927636
[26]  Modaghegh, M.S. and Hafezi, S. (2017) Endovascular Treatment of Thromboangiitis Obliterans (Buerger’s Disease). Vascular and Endovascular Surgery, 52, 124-130.
https://doi.org/10.1177/1538574417744085
[27]  王潇, 亢杰. 介入治疗在血栓闭塞性脉管炎中的临床疗效分析[J]. 临床普外科电子杂志, 2022, 10(2): 56-59.
[28]  杨肖, 刘霞, 王磊, 等. 接触性导管溶栓联合药物涂层球囊扩张治疗股腘型血栓闭塞性脉管炎的疗效分析[J]. 血管与腔内血管外科杂志, 2021, 7(11): 1279-1282.
[29]  郑鸿坚, 杨金星, 刘黎军, 等. 胫骨横向骨搬运技术治疗糖尿病足疗效分析[J]. 中国骨与关节损伤杂志, 2022, 37(4): 434-436.
[30]  陈宏, 李辉俊, 王家合, 等. 胫骨横向骨搬运技术治疗下肢血栓闭塞性脉管炎的临床研究[J]. 中国医学创新, 2023, 20(3): 15-18.
[31]  杨思捷, 陈炎, 邝晓聪, 等. 胫骨横向骨搬移术治疗下肢血栓闭塞性脉管炎[J]. 中医正骨, 2020, 32(7): 58-61.
[32]  杨金江, 杨镛, 马振桓. 干细胞移植治疗血栓闭塞性脉管炎的进展[J]. 华西医学, 2020, 35(3): 357-362.
[33]  刘浩, 方圆, 潘天岳, 等. 外周血单个核细胞与纯化CD34~+细胞移植在治疗血栓闭塞性脉管炎导致重度肢体缺血的长期疗效比较[J]. 上海医学, 2022, 45(10): 679-685.
[34]  汤敬东. 血管内射频消融治疗血栓闭塞性脉管炎疗效观察[J]. 血管与腔内血管外科杂志, 2018, 4(6): 475-479+474.
[35]  周花仙, 陆佳妮, 沈永青, 等. 腔内射频消融交感支手术及多学科团队协作模式治疗血栓闭塞性脉管炎的临床效果[J]. 血管与腔内血管外科杂志, 2018, 4(6): 531-536.
[36]  唐石晶, 郭发才, 汤敬东. 射频消融、干细胞移植及药物灌注治疗血栓闭塞性脉管炎的有效性及安全性[J]. 血管与腔内血管外科杂志, 2019, 5(2): 103-108.
[37]  Le Joncour, A., Soudet, S., Dupont, A., Espitia, O., Koskas, F., Cluzel, P., et al. (2018) Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger’s Disease): A Multicenter Study of 224 Patients. Journal of the American Heart Association, 7, e010677.
https://doi.org/10.1161/jaha.118.010677

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133